Skip to main content

Two medicines, side by side

Losartan vs minoxidil

Losartan and minoxidil are both labeled for high blood pressure. Drugs@FDA records approvals of losartan since 1995 and of minoxidil since 1979. Pharmacies paid $0.0327 per losartan potassium 50 mg tablet and $0.156 per minoxidil 10 mg tablet (NADAC, October 7, 2026); the strengths differ, so the two prices are not like for like. In FDA's classes, losartan is an angiotensin 2 receptor blocker and minoxidil an arteriolar vasodilator.

Check it at the source: the losartan FDA label on DailyMed (effective January 20, 2026); the minoxidil FDA label on DailyMed (effective September 6, 2024).

Highlights of the losartan record

Losartan (Cozaar) · label of January 20, 2026

Boxed warning

FETAL TOXICITY When pregnancy is detected, discontinue COZAAR as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions (5.1) ]. WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue COZAAR as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

Used for

From the label: indications

COZAAR is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. […]

On the market

Earliest approval on file
April 14, 1995
Generic labelers
43 labelers
Pharmacy cost
$0.0327 per tablet

Supply and safety

Shortage
No current entry
Recalls
77

Highlights of the minoxidil record

Minoxidil (Rogaine) · label of September 6, 2024

Used for

From the label: indications

to regrow hair on the scalp

On the market

Earliest approval on file
October 18, 1979
Generic labelers
86 labelers
Pharmacy cost
$0.156 per tablet

Supply and safety

Shortage
No current entry
Recalls
1

Source: FDA drug labels via openFDA (Losartan label of January 20, 2026, Minoxidil label of September 6, 2024); NDC Directory, Drugs@FDA, NADAC, FDA shortages and recalls (October 8, 2026)

How do losartan and minoxidil differ on the record?

In FDA's classes, losartan is an angiotensin 2 receptor blocker and minoxidil an arteriolar vasodilator.

Both labels carry a boxed warning; the records quote them.

Generics: losartan since 2010; minoxidil since 1987 (Drugs@FDA).

LosartanMinoxidil
Labeled forHigh blood pressure, Chronic kidney disease, Stroke preventionHigh blood pressure
Pharmacologic classAngiotensin 2 Receptor BlockerArteriolar Vasodilator
How it works (label)Angiotensin II [formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II)] is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system, and an important component …n/a
Half-life (label)The terminal half-life of losartan is about 2 hours and of the metabolite is about 6-9 hours.n/a
Earliest approval on file (Drugs@FDA)April 14, 1995October 18, 1979
First generic approvedApril 6, 2010March 3, 1987
Generic labelers (NDC)43 labelers86 labelers
Pharmacy cost (NADAC, each one's most listed form; strengths differ)$0.0327 per tablet (Losartan potassium 50 mg tablet)$0.156 per tablet (Minoxidil 10 mg tablet)
12-month price change+2%-17%
Boxed warningYesYes
Shortage nowNo current entryNo current entry
Recalls recorded771
FAERS reports (a report is not proof of cause; counts follow how widely a medicine is used)200,56644,687
DEA schedulenonenone

Source: Drugs@FDA, FDA NDC Directory, CMS NADAC of October 7, 2026, FDA shortages and recalls, FAERS via openFDA (FDA files October 8, 2026)

What next?

Alternatives to losartan
every medicine labeled for the same conditions